Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 9, 2015, Pages 15432-15440

  Ding, Mingxia ^a   Li, Yi ^b   Wang, Haifeng ^a   Lv, Yongchang ^a   Liang, Jianwei ^a   Wang, Jiansong ^a   Li, Chong ^a,c  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Bladder cancer; Diagnostic value; Meta analysis; microRNAs; Urinary

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

AREA UNDER THE CURVE; ARTICLE; BLADDER CANCER; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; META ANALYSIS; PREDICTIVE VALUE; PROTEIN EXPRESSION; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

EID: 84946554081     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Jemal A, Siegel R, Xu J and Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005; 5: 713-25.
4. Mitra AP, Datar RH and Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 2006; 24: 5552-64.
5. Neely LA, Rieger-Christ KM, Neto BS, Eroshkin A, Garver J, Patel S, Phung NA, McLaughlin S, Libertino JA, Whitney D and Summerhayes IC. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 2010; 28: 39-48.
6. Miah S, Dudziec E, Drayton RM, Zlotta AR, Morgan SL, Rosario DJ, Hamdy FC and Catto JW. An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. Br J Cancer 2012; 107: 123-8.
7. Schrier BP, Hollander MP, van Rhijn BW, Kiemeney LA and Witjes JA. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 2004; 45: 292-6.
8. Tolle A, Jung M, Rabenhorst S, Kilic E, Jung K and Weikert S. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer. Oncol Rep 2013; 30: 1949-56.
9. van Rhijn BW, van der Poel HG and van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 2005; 47: 736-48.
10. Wang W, Li T and Li CW. [The analysis of miR-17-5p expression in urine for bladder cancer diagnosis]. Medical Journal of Air Force 2013; 29: 143-5+54.
11. Planz B, Jochims E, Deix T, Caspers HP, Jakse G and Boecking A. The role of urinary cytology for detection of bladder cancer. Eur J Surg Oncol 2005; 31: 304-8.
12. van der Poel HG and Debruyne FM. Can biological markers replace cystoscopy? An update. Curr Opin Urol 2001; 11: 503-9.
13. Simon MA, Lokeshwar VB and Soloway MS. Current bladder cancer tests: unnecessary or beneficial? Crit Rev Oncol Hematol 2003; 47: 91-107.
14. Giannopoulos A, Manousakas T, Gounari A, Constantinides C, Choremi-Papadopoulou H and Dimopoulos C. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors. J Urol 2001; 166: 470-5.
15. Mahnert B, Tauber S, Kriegmair M, Nagel D, Holdenrieder S, Hofmann K, Reiter W, Schmeller N and Stieber P. Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer? Clin Chem Lab Med 2003; 41: 104-10.
16. Zhang W, Dahlberg JE and Tam W. MicroRNAs in tumorigenesis: a primer. Am J Pathol 2007; 171: 728-38.
17. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
18. Esquela-Kerscher A and Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
19. Kent OA and Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25: 6188-96.
20. Kusenda B, Mraz M, Mayer J and Pospisilova S. MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006; 150: 205-15.
21. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D and Slack FJ. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007; 67: 7713-22.
22. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F and Croce CM. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99: 15524-9.
23. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, Warnecke JM and Sczakiel G. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010; 28: 655-61.
24. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N and Nakagawa M. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade and comparison with urinary cytology. Cancer Sci 2011; 102: 522-9.
25. Puerta-Gil P, Garcia-Baquero R, Jia AY, Ocana S, Alvarez-Mugica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F and Sanchez-Carbayo M. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol 2012; 180: 1808-15.
26. Wang G, Chan ES, Kwan BC, Li PK, Yip SK, Szeto CC and Ng CF. Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer 2012; 10: 106-13.
27. Catto JW, Miah S, Owen HC, Bryant H, Myers K, Dudziec E, Larre S, Milo M, Rehman I, Rosario DJ, Di Martino E, Knowles MA, Meuth M, Harris AL and Hamdy FC. Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 2009; 69: 8472-81.
28. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhoi BP, Kjems J, Borre M and Orntoft TF. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 2009; 69: 4851-60.
29. Hideki E, Chiyomaru T, Masahiko I, Kojima S, Nishiyama K, Naohiko S and Masayuki N. Micrornas detection in urine samples from patients with urothelial carcinoma. European Urology, Supplements 2010; 9: 47.
30. Enokida H, Yamada Y, Yoshino H, Tatarano S, Hidaka H, Yamasaki T, Chiyomaru T, Kojima S, Seki N and Nakagawa M. Micrornas detection in urine as diagnostic markers and predictors of recurrence of non-muscle invasive bladder cancer. J Urol 2012; 187: e514.
31. Snowdon J, Boag S, Feilotter H, Izard J and Siemens DR. A pilot study of urinary microRNA as a biomarker for urothelial cancer. Can Urol Assoc J 2012: 1-5.
32. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA and Bossuyt PM. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-36.
33. Glas AS, Lijmer JG, Prins MH, Bonsel GJ and Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-35.
34. Altman DG and Bland JM. Diagnostic tests 3: receiver operating characteristic plots. BMJ 1994; 309: 188.
35. Ferreira Antunes JL. A dictionary of epidemiology. J Epidemiol Community Health 2009; 63: 337.
36. Higgins JP, Thompson SG, Deeks JJ and Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
37. Dinnes J, Deeks J, Kirby J and Roderick P. A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technol Assess 2005; 9: 1-113, iii.
38. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M and Seki N. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 2009; 125: 345-52.
39. Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva Neto B, Lavoie AK, Logvinenko T, Libertino JA and Summerhayes IC. A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urol Oncol 2011; 29: 794-801, e1.
40. Manganiello M, Faust W, Zbrzezny J, Deliyiannis C, Waknitz M, Huang W, Gee J, Libertino JA, Holway A and Rieger-Christ K. Multi-institutional evaluation of a microrna expression profile defining the invasive bladder tumor phenotype. J Urol 2012; 187: e433.
41. Adam L, Wszolek MF, Liu CG, Jing W, Diao L, Zien A, Zhang JD, Jackson D and Dinney CP. Plasma microRNA profiles for bladder cancer detection. Urol Oncol 2013; 31: 1701-8.
42. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N and Nakagawa M. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: Correlation with stage and grade and comparison with urinary cytology. Cancer Sci 2011; 102: 522-9.
43. Miah S, Dudziec E, Drayton RM, Zlotta AR, Morgan SL, Rosario DJ, Hamdy FC and Catto JW. An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. Br J Cancer 2012; 107: 123-8.
44. Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS, Song PH, Choi YH, Kim IY, Moon SK and Kim WJ. Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer. Int J Oncol 2012; 41: 1871-8.
45. Mengual L, Lozano JJ, Ingelmo-Torres M, Gazquez C, Ribal MJ and Alcaraz A. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer. Int J Cancer 2013; 133: 2631-41.
46. Song J, Su H, Zhou YY and Guo LL. Cyclooxygenase-2 expression is associated with poor overall survival of patients with gastric cancer: a meta-analysis. Dig Dis Sci 2014; 59: 436-45.
47. Eissa S, Matboli M, Hegazy MG, Kotb YM and Essawy NO. Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to bilharziasis. Transl Res 2015; 165: 731-9.